MG
RCKT icon

Meditor Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Meditor Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,149
Closed -$142K – 4
2015
Q4 		$142K Sell
3,149
-9,629
-75% -$420K 0.07% 4
2015
Q3 		$480K Buy
+12,778
New +$587K 0.25% 4

Other funds holding RCKT

DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $92.2B AUM 15.8% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $4.2B AUM 21.45% 1-Year Est. Return